Literature DB >> 31992565

Esketamine for treatment resistant depression is not recommended by NICE.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2020        PMID： 31992565     DOI： 10.1136/bmj.m329

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Esketamine clinical trials: reply to Maju et al.

Authors:  C Gastaldon; D Papola; G Ostuzzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-29       Impact factor: 6.892

Review 2.  Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review.

Authors:  Johanna Louise Keeler; Janet Treasure; Mario F Juruena; Carol Kan; Hubertus Himmerich
Journal:  Nutrients       Date:  2021-11-20       Impact factor: 5.717
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.